PsiQuantum and the National Cancer Center Japan (NCC Japan) have signed a collaborative research agreement to accelerate the development of utility-scale quantum computing applications in oncology and healthcare. This strategic partnership aims to leverage fault-tolerant quantum algorithms to solve complex challenges in drug discovery, resource allocation, and patient outcomes. By simulating molecular systems with unprecedented chemical accuracy and speed, the collaboration seeks to bypass the high costs and lengthy timelines associated with current classical pharmaceutical R&D, ultimately providing a direct path from theoretical simulations to real-world clinical treatments.
Central to this collaboration is the use of PsiQuantum’s Construct software suite, a comprehensive platform designed for the full lifecycle of fault-tolerant quantum algorithms. The Construct environment features specialized tools such as Workbench for symbolic algorithm definition, Qubricks—a collection of modular, optimized building blocks for chemistry and materials science—and a Resource Analyzer to identify computational bottlenecks. These tools will enable researchers at NCC Japan and partner pharmaceutical companies to design and optimize algorithms specifically for large-scale photonic quantum systems, ensuring they are prepared to deploy clinically relevant applications as soon as utility-scale hardware is available.
The partnership is led by Dr. Takayuki Yoshino, Director of the Department of Global Oncology at NCC Hospital East, and Sam Pallister, PsiQuantum’s Vice President for Quantum Applications. This initiative aligns with Japan’s broader National Quantum Strategy and builds upon existing domestic research infrastructure, including the NCC’s recent collaborations with RIKEN on medical quantum computing. By integrating PsiQuantum’s photonic hardware roadmap with NCC Japan’s deep expertise in biotechnology and oncology, the team aims to establish a new frontier in personalized medicine and innovative cancer therapeutics.
For full details on the oncology roadmap and the Construct platform, consult the official PsiQuantum announcement here.
In GQI Portal
The players behind the news
The team that writes QCR tracks every company, deal and technology in the GQI Factory, GQI's verified database of the quantum industry. Next up: every story linked to its players, coming to QCR's paid plans.
- Players Companies and institutions across the quantum industry, by segment.
- Scorecards How the players compare on hardware, software, funding and more.
Newsletter
QCR Alerts in your inbox
The latest reporting and analysis from Quantum Computing Report. Free, unsubscribe any time.